Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1479-5876

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies ; volume:15 ; number:1 ; day:9 ; month:2 ; year:2017 ; pages:1-11 ; date:12.2017
Journal of translational medicine ; 15, Heft 1 (9.2.2017), 1-11, 12.2017

Keyword: Krebs
Onkologie

Creator: William, Doreen

Contributor: Mullins, Christina Susanne
Schneider, Björn
Orthmann, Andrea
Lamp, Nora
Krohn, Mathias
Hoffmann, Annika
Classen, Carl-Friedrich
Linnebacher, Michael
SpringerLink (Online service)

DOI: 10.1186/s12967-017-1128-5

URN: urn:nbn:de:1111-2017030512575

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:54 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

William, Doreen
Mullins, Christina Susanne
Schneider, Björn
Orthmann, Andrea
Lamp, Nora
Krohn, Mathias
Hoffmann, Annika
Classen, Carl-Friedrich
Linnebacher, Michael
SpringerLink (Online service)

Other Objects (12)

Patient-derived xenografts as preclinical neuroblastoma models

Mifepristone improves chemo-radiation response in glioblastoma xenografts

Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts

Patient-derived xenografts: a relevant preclinical model for drug development

Optimized scaling of translational factors in oncology: from xenografts to RECIST

Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts

Eradication of Glioblastoma, and Breast and Colon Carcinoma Xenografts by Hsp70 Depletion

Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma

Novel therapeutic venues for glioblastoma: novel rising preclinical treatment opportunities

Preclinical and clinical advances to overcome hypoxia in glioblastoma multiforme

Implementing patient-derived xenografts to assess the effectiveness of cyclin-dependent kinase inhibitors in glioblastoma

Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy

Patient-derived xenografts as preclinical neuroblastoma models

Mifepristone improves chemo-radiation response in glioblastoma xenografts

Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts

Patient-derived xenografts: a relevant preclinical model for drug development

Optimized scaling of translational factors in oncology: from xenografts to RECIST

Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts

Eradication of Glioblastoma, and Breast and Colon Carcinoma Xenografts by Hsp70 Depletion

Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma

Novel therapeutic venues for glioblastoma: novel rising preclinical treatment opportunities

Preclinical and clinical advances to overcome hypoxia in glioblastoma multiforme

Implementing patient-derived xenografts to assess the effectiveness of cyclin-dependent kinase inhibitors in glioblastoma

Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy

Patient-derived xenografts as preclinical neuroblastoma models

Mifepristone improves chemo-radiation response in glioblastoma xenografts

Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts

Patient-derived xenografts: a relevant preclinical model for drug development

Optimized scaling of translational factors in oncology: from xenografts to RECIST

Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts

Eradication of Glioblastoma, and Breast and Colon Carcinoma Xenografts by Hsp70 Depletion

Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma

Novel therapeutic venues for glioblastoma: novel rising preclinical treatment opportunities

Preclinical and clinical advances to overcome hypoxia in glioblastoma multiforme

Implementing patient-derived xenografts to assess the effectiveness of cyclin-dependent kinase inhibitors in glioblastoma

Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Patient-derived xenografts as preclinical neuroblastoma models

Mifepristone improves chemo-radiation response in glioblastoma xenografts

Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts

Patient-derived xenografts: a relevant preclinical model for drug development

Optimized scaling of translational factors in oncology: from xenografts to RECIST

Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts

Eradication of Glioblastoma, and Breast and Colon Carcinoma Xenografts by Hsp70 Depletion

Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma

Novel therapeutic venues for glioblastoma: novel rising preclinical treatment opportunities

Preclinical and clinical advances to overcome hypoxia in glioblastoma multiforme

Implementing patient-derived xenografts to assess the effectiveness of cyclin-dependent kinase inhibitors in glioblastoma

Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy

Patient-derived xenografts as preclinical neuroblastoma models

Mifepristone improves chemo-radiation response in glioblastoma xenografts

Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts

Patient-derived xenografts: a relevant preclinical model for drug development

Optimized scaling of translational factors in oncology: from xenografts to RECIST

Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts

Eradication of Glioblastoma, and Breast and Colon Carcinoma Xenografts by Hsp70 Depletion

Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma

Novel therapeutic venues for glioblastoma: novel rising preclinical treatment opportunities

Preclinical and clinical advances to overcome hypoxia in glioblastoma multiforme

Implementing patient-derived xenografts to assess the effectiveness of cyclin-dependent kinase inhibitors in glioblastoma

Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy

Patient-derived xenografts as preclinical neuroblastoma models

Mifepristone improves chemo-radiation response in glioblastoma xenografts

Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts

Patient-derived xenografts: a relevant preclinical model for drug development

Optimized scaling of translational factors in oncology: from xenografts to RECIST

Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts

Eradication of Glioblastoma, and Breast and Colon Carcinoma Xenografts by Hsp70 Depletion

Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma

Novel therapeutic venues for glioblastoma: novel rising preclinical treatment opportunities

Preclinical and clinical advances to overcome hypoxia in glioblastoma multiforme

Implementing patient-derived xenografts to assess the effectiveness of cyclin-dependent kinase inhibitors in glioblastoma

Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy

Related objects

Reset password